| __timestamp | GSK plc | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3450000000 | 2242216 |
| Thursday, January 1, 2015 | 3560000000 | 4536244 |
| Friday, January 1, 2016 | 3628000000 | 5184803 |
| Sunday, January 1, 2017 | 4476000000 | 3068742 |
| Monday, January 1, 2018 | 3893000000 | 7178000 |
| Tuesday, January 1, 2019 | 4568000000 | 16267000 |
| Wednesday, January 1, 2020 | 5098000000 | 23191000 |
| Friday, January 1, 2021 | 5278000000 | 21453000 |
| Saturday, January 1, 2022 | 5488000000 | 15265000 |
| Sunday, January 1, 2023 | 6223000000 | 25189000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, GSK plc and Soleno Therapeutics, Inc. have taken markedly different paths in their R&D investments. GSK, a global healthcare giant, has consistently increased its R&D budget, peaking at approximately $6.2 billion in 2023, a 44% rise from 2014. In contrast, Soleno Therapeutics, a smaller player, has seen its R&D expenses grow from a modest $2.2 million in 2014 to $25.2 million in 2023, marking an impressive 1,030% increase.
This stark contrast highlights the diverse strategies within the industry. While GSK leverages its vast resources to maintain a steady innovation pipeline, Soleno's exponential growth in R&D spending underscores its commitment to breakthrough therapies. As the pharmaceutical landscape continues to shift, these companies exemplify the dynamic nature of R&D investment strategies.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and GSK plc
Research and Development: Comparing Key Metrics for GSK plc and Amneal Pharmaceuticals, Inc.
Research and Development Investment: GSK plc vs Galapagos NV
Research and Development Expenses Breakdown: Alnylam Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Soleno Therapeutics, Inc.
R&D Insights: How Bio-Techne Corporation and Soleno Therapeutics, Inc. Allocate Funds
Ultragenyx Pharmaceutical Inc. or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Veracyte, Inc. vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: ImmunityBio, Inc. vs Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. or MannKind Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Dynavax Technologies Corporation